澳大利亚细菌性医疗保健相关感染的可归因住院时间、死亡风险与费用:回顾性病例队列研究
结果显示血流感染健康负担最重,但尿路与呼吸道感染对医疗系统支出贡献最大,耐药显著延长特定血流感染住院时间。
要点
- 血流感染健康负担最重,但尿路和呼吸道感染对医疗支出贡献最大。
- 耐三代头孢肺炎克雷伯菌血流感染额外住院4.6天,耐甲氧西林金葡菌血流感染额外2.9天。
- 5种目标菌感染总体发病率为116.9例/10万患者日,大肠埃希菌尿路感染占比最大(51例/10万患者日)。
核心结论
- 血流感染的健康负担仍最高,但尿路和呼吸道感染对医疗系统支出贡献最大。
- 耐药显著增加特定血流感染患者的住院时间和医疗费用。
研究设计与样本
- 多中心回顾性病例队列研究,纳入2012年1月1日至2016年12月30日所有急性护理医院 admissions 中5种目标菌(大肠埃希菌、肺炎克雷伯菌、铜绿假单胞菌、金黄色葡萄球菌、屎肠球菌)培养阳性的患者。
- 通过数据链接生成全州医院入院和病理数据集,纳入血流、尿路或呼吸道感染患者,并匹配无感染患者样本。
- 采用多状态生存模型生成住院时间,逻辑回归推导死亡率估计。
主要发现
- 5种目标菌感染总体发病率为116.9例/10万患者日,大肠埃希菌尿路感染贡献最大比例(51例/10万患者日)。
- 尿路感染对住院时间的影响在5种病原体中均较中等。
- 耐药显著延长耐三代头孢肺炎克雷伯菌血流感染患者住院时间(额外4.6天)和耐甲氧西林金黄色葡萄球菌血流感染患者住院时间(额外2.9天)。
- 上述耐药感染相比相应敏感菌株感染,医疗费用更高。
临床怎么用
- 应关注尿路和呼吸道感染对医疗系统支出的较大贡献,优化感染防控与抗菌药物管理。
- 对耐三代头孢肺炎克雷伯菌和耐甲氧西林金黄色葡萄球菌血流感染应重视其额外住院时间和费用负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Unbiased estimates of the health and economic impacts of health care-associated infections (HAIs) are scarce and focus largely on patients with bloodstream infections (BSIs). We sought to estimate the hospital length of stay (LOS), mortality rate, and costs of HAIs and the differential effects on patients with an antimicrobial-resistant infection. METHODS: We conducted a multisite, retrospective case-cohort of all acute-care hospital admissions with a positive culture of 1 of the 5 organisms of interest (Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, or Enterococcus faecium) from 1 January 2012 through 30 December 2016. Data linkage was used to generate a data set of statewide hospital admissions and pathology data. Patients with bloodstream, urinary, or respiratory tract infections were included in the analysis and matched to a sample of uninfected patients. We used multistate survival models to generate LOS, and logistic regression to derive mortality estimates. RESULTS: We matched 20 390 cases to 75 635 uninfected control patients. The overall incidence of infections due to the 5 studied organisms was 116.9 cases per 100 000 patient days, with E. coli urinary tract infections (UTIs) contributing the largest proportion (51 cases per 100 000 patient days). The impact of a UTI on LOS was moderate across the 5 studied pathogens. Resistance significantly increased LOS for patients with third-generation cephalosporin-resistant K. pneumoniae BSIs (extra 4.6 days) and methicillin-resistant S. aureus BSIs (extra 2.9 days). Consequently, the health-care costs of these infections were higher, compared to corresponding drug-sensitive strains. CONCLUSIONS: The health burden remains highest for BSIs; however, UTIs and respiratory tract infections contributed most to the health-care system expenditure.
引用
- Lee XJ, Stewardson AJ, Worth LJ, et al. Attributable Length of Stay, Mortality Risk, and Costs of Bacterial Health Care-Associated Infections in Australia: A Retrospective Case-cohort Study. Clin Infect Dis. 2021. PMID: 32822465. doi:10.1093/cid/ciaa1228
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。